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Abstract
The use of plant biotechnology in agriculture approaches the end of its second
decade. While it is now a maturing industry in the Americas, Asia, and Australasia
in particular, in some parts of the world, no more so than in Europe, it
remains a highly controversial issue. European authorities have responded to
the controversy by establishing a regulatory framework so impenetrable that
development of the technology in Europe has effectively ground to a halt and
the United Kingdom, for example, is no nearer to the commercial cultivation
of genetically modified (GM) crops than it was when the first GM varieties
went on the market in the United States of America in the mid-1990s. This
review covers the GM crop varieties and traits that have been launched in the
last 18 years, including the failures as well as successes, and considers the
prospects for the technology.
History
Modern, scientific plant breeding arose from the rediscov-
ery of Mendel’s 1866 work, “Versuche uber Pflanzen-
Hybride,” in 1900. The “Russett Burbank” hybrid potato
(Solanum tuberosum) variety was launched in 1923 and
the first hybrid maize (Zea mays) variety was not released
until 1933. By the 1950s, scientists were using chemical
and radiation mutagenesis to increase the genetic varia-
tion from which they could breed new varieties, and in
the 1960s and 1970s, thanks to the inspiration of Norman
Borlaug, dwarfing genes were incorporated into breeding
programs worldwide, bringing about the “Green Revolu-
tion” and averting a global food crisis.
Advances in molecular biology were being made rapidly
at this time and the first recombinant DNA molecule was
reported by Berg and coworkers in 1972 (Jackson et al.
1972). Five years later, in 1977, Chilton and coworkers
described the natural genetic modification of host plant
cells by Agrobacterium tumefaciens (Chilton et al. 1977)
and only 6 years after that, in 1983, Hall reported the
production of genetically modified (GM) sunflower
(Helianthus annuus) plants containing a gene from bean
(Phaseolus vulgaris) (Murai et al. 1983). Eleven years on,
in 1994, a U.S. company, Calgene, launched a GM tomato
(Lycopersicon esculentum) variety “Flavr Savr” and by
1996 the first significant areas of GM commodity crops,
soybean (Glycine max) and maize, were being grown, and
the genie was irrefutably out of the bottle.
Definitions
At this point, it would be useful to define what is meant
by GM. New varieties of crops are usually marketed with
claims of improved traits of one sort or another com-
pared with currently available varieties, and traits are
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genetically controlled. In the United Kingdom, new varie-
ties of agricultural and vegetable species must be placed
on a National List to be eligible for certification and mar-
keting. To be added to the National List, a variety must
be “distinct, sufficiently uniform, and stable (DUS)” and,
for agricultural crops, “have satisfactory value for cultiva-
tion and use (VCU)” (http://www.fera.defra.gov.uk/
plants/plantVarieties/nationalListing/). This is a legal
requirement and a new variety will only be added to the
list if it is genuinely new and an improvement on varie-
ties already available. Essentially, this means that a new
variety must be genetically different from any other vari-
ety already on the market. However, it would not be
described as GM: that term has come to be used specifi-
cally to describe a plant or variety that contains a gene or
genes that have been introduced artificially, and no varie-
ties of that sort are currently being marketed in the
United Kingdom. Such plants are also described as being
transgenic, having been transformed, or as genetically
engineered (GE).
Genetic modification is therefore a term that is based
on the technique that is used to produce a GM plant, not
on the nature of the plant. In that respect, it is somewhat
unsatisfactory because technology continues to move on.
Several methods already available to the plant biotechnol-
ogist use the common soil bacterium, Agrobacterium
tumefaciens, which will infect wounded plant tissue and
insert a short section of DNA, called the transfer DNA or
T-DNA, into the host plant genome (Chilton et al. 1977).
A. tumefaciens can be used through the infection of
explants or protoplasts and the regeneration of GM plants
from tissue-cultured transformed cells. Methods have also
been developed that do not require tissue culture, such as
floral dip (Bechtold et al. 1993; Clough and Bent 1998),
in which plants at the early stages of flowering are placed
in a suspension of A. tumefaciens in a vacuum jar, a vac-
uum is applied to remove air surrounding the plant tissue
and allow the bacteria to come into contact with the
plant cells, and the plants are grown to seed. Typically,
approximately 1% of the seeds are genetically modified.
This method is now widely used in basic research using
Arabidopsis (Arabidopsis thaliana) and has been adapted
with some success for use with other plant species,
including soybean and rice (Oryza sativa).
Protoplasts can also be induced to take up DNA
directly, either by treatment with polyethylene glycol
(PEG) or by electroporation. This process is called direct
or DNA-mediated gene transfer and in a small proportion
of the protoplasts, the introduced DNA will integrate into
the host DNA and the protoplast will be stably trans-
formed. The protoplast can then be induced to form cal-
lus, from which a GM plant can be regenerated.
Electroporation can be applied to intact cells in tissue
pieces or in suspension, as well as to protoplasts, but this
has only been shown to work efficiently in a few species.
Another direct gene transfer method to have been
developed is silicon carbide fiber vortexing. Plant cells are
suspended in a medium containing DNA and microscopic
silicon carbide fibers. The suspension is vortexed and the
fibers penetrate the plant cell walls, allowing the DNA to
enter. Finally, there is particle bombardment, in which
plant cells are bombarded with tiny particles coated with
DNA. Particle bombardment has been particularly suc-
cessful in the production of GM cereals and the subcul-
turing of shoots of GM wheat (Triticum aestivum)
forming from callus derived from the particle bombard-
ment of embryos is shown in Figure 1. However, it has
the disadvantage that the GM plant that is produced is
often found to have multiple copies of the transgene. This
makes genetic analysis of the GM plant and the produc-
tion of a homozygous line from it more difficult. It has
also been a problem in obtaining permission for market-
ing in Europe, where regulators expect to receive detailed
information on all of the sites where the transgene has
been inserted. The method was developed in part because
A. tumefaciens-mediated transformation of cereals used to
be very difficult. Strains of the bacterium have now been
developed that infect and transform cereals much more
efficiently and this is probably going to be the preferred
option in cereal biotechnology in the future.
In recent years, commentators have begun to use the
terms first and second generation to describe commercial
GM crop applications that involve input traits and output
traits, respectively. Input traits affect the husbandry and
management of a crop, and include, for example, herbi-
cide tolerance, resistance to insects or pathogens, and the
ability to survive stress conditions, such as drought.
Farmers are the principal beneficiaries, although consum-
ers may benefit indirectly through lower food prices.
Figure 1. Subculturing shoots forming from callus derived from
particle bombardment of wheat (Triticum aestivum) embryos. Picture
kindly provided by Rothamsted Research.
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Output traits affect the composition of the crop product
and include, for example, changes in the fatty acid com-
position of oils, changes in starch quality, improved
nutritional value, for example, through increased vitamin
content, or better processing properties. The main benefi-
ciaries are consumers and/or food processors.
GM varieties with improved input traits have undoubt-
edly been easier to sell to farmers, and farmers are the
customers of seed companies, not food processors, retail-
ers or consumers. Some of these varieties are now well
established and have been extremely successful, while vari-
eties with improved output traits have been relatively
marginal. The terms first and second generation have been
used to highlight the fact that more GM varieties with
improved output traits are expected to come to the mar-
ket in the near future. However, they reflect a simplistic
view, firstly because the first GM variety on the market
back in 1994 was the “FlavrSavr” tomato, a variety with
improved shelf life (an output trait); secondly, because
output traits are likely to be combined with (first genera-
tion) input traits, providing added value to varieties with
traits that farmers are already familiar with and want.
New Technologies
Genetic modification of plants is now almost three dec-
ades old. Not surprisingly, technology has moved on, and
there are a number of new techniques that may or may
not come under the GM banner and, therefore, GM regu-
lations. Indeed, the European Commission set up a work-
ing group in December 2008 to decide how these new
techniques should be regulated. The techniques include
the following:
Cisgenesis (sometimes called intragenesis)
This is not really a new technique, it simply refers to
genetic modification using one of the techniques described
above, but using no “foreign” DNA; in other words, the
manipulation is done using DNA entirely from the same
species as the host plant, or a species that is closely related
enough to be sexually compatible. The use of the term is
an attempt to distinguish GM plants or other organisms
produced in this way from transgenics, that is GM plants
that contain DNA from unrelated organisms. It has been
argued that cisgenic GM plants should not be regulated in
the same way as transgenic GM plants (Schouten et al.
2006), and the Symplot company of the U.S.A., for exam-
ple, has used what it called “all-native” DNA to transform
potatoes to reduce acrylamide formation during process-
ing (Rommens et al. 2006). It has proven difficult to
establish a market for GM potatoes even in the United
States of America and Symplot may be trying to allay fears
by using this technique. However, it is not clear yet
whether the strategy will be successful in the United States
of America and it seems unlikely that cisgenics will be
treated any differently to transgenics in Europe.
Zinc-finger nuclease technology
Zinc-finger nucleases are artificial enzymes produced by
fusing a zinc-finger binding domain to the nonspecific
DNA cleavage domain of a restriction enzyme, usually
that of FokI. The zinc-finger domain can be engineered
to target a specific nucleotide sequence, and the cleavage
domain must dimerize to work, so two nucleases are
required, one to bind to each strand of the DNA,
increasing the specificity. The host cell’s own enzymes
repair the DNA, resulting in highly specific, targeted
alterations to the DNA sequence; a form of targeted
mutagenesis. The technique has been demonstrated to
work in tobacco (Nicotiana tabacum) protoplasts (Town-
send et al. 2009).
Oligonucleotide-directed mutagenesis
Oligonucleotide-directed mutagenesis (ODGM) is another
technique devised to introduce specific mutations at
defined sites of the genome. It is based on site-specific
mutation of a target gene by the introduction of an oligo-
nucleotide with an identical nucleotide sequence to the
target gene apart from the nucleotide to be substituted.
The oligonucleotide, usually between 20 and 100 nucleo-
tides in length, is delivered by electroporation or PEG-
mediated transfection of protoplasts, and interacts with
the target gene. It does not actually insert into the gen-
ome; rather, as with the zinc-finger nuclease technique,
the mutation is incorporated into the genomic DNA by
the native DNA repair machinery. The technique has been
successful using single-stranded DNA oligonucleotides,
RNA oligonucleotides, or chimeric oligonucleotides con-
sisting of both RNA and single-stranded DNA. Triple
helix-forming oligonucleotides (TFOs) have also been
used; a triple helix can form when a TFO binds in a
sequence-specific manner in the major groove of duplex
DNA. The technique therefore has a variety of alternative
names, depending on the type of oligonucleotide used,
the delivery method and the specific application. These
include targeted nucleotide exchange, chimeraplasty,
oligonucleotide-mediated gene editing, chimeric oligonu-
cleotide-dependent mismatch repair, oligonucleotide-mediated
gene repair, triplex-forming oligonucleotide-induced
recombination, therapeutic nucleic acid repair, and tar-
geted gene repair.
ODGM has been used successfully in plants (Beetham
et al. 1999; Zhu et al. 1999; Kochevenko and Willmitzer
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2003) and the U.K.’s Advisory Committee for Releases
to the Environment was asked for an opinion on an
oilseed rape variety developed by Cibus Global that
could tolerate sulfonylurea herbicides as a result of a
mutation introduced by ODGM. The Committee
concluded that organisms produced by mutagenesis
could be excluded from European Union (EU) directives
covering GM organisms as long as they did not contain
recombinant nucleic acid molecules (http://www.defra.
gov.uk/acre/files/20110319-Cibus-advice.pdf, 7 March 2011).
The United States Department of Agriculture reached a
similar conclusion, but the European Food Safety
Authority (EFSA) has not yet delivered its opinion on
the matter.
RNA-dependent DNA methylation
RNA interference is an established GM technique that
exploits natural mechanisms of RNA silencing (reviewed
by Baulcombe 2004). A plant is modified to synthesize a
double-stranded RNA molecule derived from a target
gene, for example, by using a gene construct in which
part of the gene is spliced sequentially in a head-to-tail
formation downstream of a single promoter. This causes
the production of an RNA molecule that forms a hairpin
loop (hpRNA); this molecule is cleaved into short, dou-
ble-stranded RNA molecules by an enzyme called Dicer
that is naturally present in the cell. These short RNA
molecules are called short interfering RNAs (siRNAs).
The siRNAs are unwound into two single-stranded mole-
cules, one of which (the passenger strand) is degraded,
while the other (the guide strand) is incorporated into a
RNA-induced silencing complex (RISC). The guide strand
pairs with the complementary sequence of messenger
RNA from the target gene, and induces cleavage by
another enzyme, Argonaute, which is present in the
RISC.
Plants also use double-stranded RNAs (dsRNAs) to
induce cytosine methylation of DNA, leading to the for-
mation of transcriptionally silent heterochromatin. The
RNAs that trigger DNA methylation can come from a
variety of sources, including viruses and transposons.
However, promoter methylation and transcriptional
silencing has been demonstrated in plants as a result of
dsRNA arising from a transgene (Mette et al. 2000).
Agro-infiltration
In this method, transient expression of a gene is achieved
by introducing a suspension of A. tumefaciens to the
underside of a plant leaf, usually via a syringe without a
needle. The Agrobacterium enters the air spaces within the
leaf via the stomata and delivers the transgene to some of
the leaf cells. Alternatively, leaves, leaf disks or even whole
plants are placed in a beaker containing the Agrobacterium
suspension. The beaker is then placed in a vacuum cham-
ber and a vacuum applied, forcing air out of the stomata.
When the vacuum is released, the bacteria are drawn deep
into the leaf tissue. Either way, the plant is not stably
transformed and the transgene is not inherited, so while
this technique will no doubt be useful in the study of
plant gene function, it has little relevance to commercial
agriculture.
Why Use GM?
Plant breeding has been extremely successful; average
U.K. wheat yield at the turn of the 20th century, for
example, was around two tonnes per hectare, whereas it
is now around four times that. While mechanization and
the development of artificial fertilizers, pesticides, and
herbicides have contributed significantly to that improve-
ment, plant breeding has also played an important part.
This spectacular improvement has been achieved without
the use of biotechnology, and the genetic information
and resources available to assist in non-GM breeding in
the genomics era greatly exceed what previous generations
of plant breeders had to work with. So do we need GM
at all?
The answer to that question is that GM enables plant
breeders to do some things that would not be possible by
other methods. GM is an additional tool in the plant
breeder’s box; not sweeping everything else away and not
a panacea that is applicable to every plant breeding pro-
gram, but nevertheless, a powerful technique when
applied to an appropriate target. For example, it allows
genes to be introduced into a crop plant from any source:
sexual compatibility is not required. It is relatively precise,
in that single genes can be transferred, and genes can be
designed to be active at different stages of a plant’s devel-
opment or in specific organs, tissues or cell types, some-
thing that is not possible by any other method. A gene
can also be altered before being engineered into the host
plant to change the properties of the protein that it
encodes, and the nature and properties of the protein can
be studied to ensure that the gene is safe to use.
GM also has some disadvantages. A successful GM pro-
gram requires background knowledge of a gene, the pro-
tein that it encodes, and the other genes and proteins that
interact with it. This requires a significant investment of
time and money compared, for example, with the genera-
tion of random mutations. Most significantly, however,
GM varieties have to undergo much more detailed analy-
sis and testing than new non-GM varieties, particularly in
Europe, and this incurs a substantial cost. Anecdotal
reports from the plant biotechnology industry put the
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estimated cost of developing a new GM variety at $100
million. This sort of investment is beyond the capability
of most plant breeding organizations and represents a
considerable risk for any company. Historically, regula-
tions covering new technologies are gradually relaxed as
the technology is shown to be safe to use, and the costs
of regulatory compliance reduce. However, there is no
sign of that happening with plant biotechnology, at least
in Europe, and the need for producers to have access to
the huge European food market means that obtaining
permission to sell a new GM variety in Europe is essential
in most cases. European attitudes to GM and the result-
ing regulations therefore affect the development of new
GM varieties and traits throughout the world, and there
are still only a handful of GM traits that have been used
successfully in commercial agriculture. These are
described in the following section.
Traits
Herbicide tolerance
Herbicide tolerance, along with insect resistance, took
commercial plant biotechnology into global commodity
crops and it remains the most successful and widely used
GM crop trait. The strategy is a simple one: genetically
modify a crop plant to tolerate a broad range herbicide;
that is, a herbicide that kills any plant not carrying the tol-
erance gene. Most herbicides are selective in the types of
plant that they kill and a farmer has to use a combination
of herbicides that are tolerated by the crop, but kill the
problem weeds. The herbicide regime may be complicated,
some of the herbicides may only be effective pre-emer-
gence, some may be toxic and difficult to handle safely, the
equipment and labor required may be costly and the
farmer has to be careful that herbicides applied one season
do not persist to the next if a different crop is to be
planted. Using GM crops that tolerate broad-range herbi-
cides (GM-HT crops) eradicates many of these problems
and not surprisingly, therefore, GM-HT varieties have been
extremely popular wherever farmers have been allowed to
use them. The first GM-HT variety to be introduced was a
“Roundup-Ready” soybean, which was produced by
Monsanto and has been marketed since 1996. Varieties
carrying this trait now dominate global soybean production.
“Roundup” is Monsanto’s trade name for glyphosate, a
broad range herbicide that was introduced as a commer-
cial product in 1974 and therefore had two decades of
use by farmers and gardeners, primarily to clear fields or
to remove weeds from pathways, prior to the develop-
ment of GM-HT varieties. It is not persistent and is taken
up through the foliage of a plant, so can be applied “over
the top” after the GM-HT crop is established, if necessary.
Its target is 5-enolpyruvoylshikimate 3-phosphate synthase
(EPSPS), the enzyme that catalyzes the formation of 5-e-
nolpyruvoylshikimate 3-phosphate from phosphoenolpyr-
uvate and shikimate 3-phosphate (Fig. 2). This reaction is
the penultimate step in the shikimate pathway, which
results in the formation of chorismate, which in turn is
required for the synthesis of many aromatic plant metab-
olites, including the amino acids phenylalanine, tyrosine,
and tryptophan. The shikimate pathway is not present in
animals, making glyphosate relatively nontoxic to animals,
including man, and glyphosate is regarded by farmers as
one of the safest agrochemicals to use. The familiarity of
glyphosate undoubtedly helped to persuade farmers to
adopt glyphosate-tolerant GM varieties when the varieties
were launched.
Genetic modification of soybean to tolerate glyphosate
(Padgette et al. 1995) was achieved by introducing an
EPSPS gene from A. tumefaciens under the control of a
Cauliflower mosaic virus (CaMV) 35S RNA (CaMV35S)
gene promoter. The bacterial EPSPS is not affected by
glyphosate, so plants carrying the transgene continue to
have a functional shikimate pathway even when their own
EPSPS is inhibited by the herbicide.
Glyphosate tolerance has now been engineered into
cotton (Gossypium hirsutum), oilseed rape (Brassica
napus), maize, alfalfa (Medicago sativa), sugar beet and
fodder beet (Beta vulgaris). Brookes and Barfoot (2011)
estimate a global increase in farm income of over 21 bil-
lion U.S. dollars between 1996 and 2007 from glyphosate-
tolerant soybean alone, but perhaps the most convincing
endorsement of the technology comes from the fact that
farmers have adopted glyphosate-tolerant varieties with
enthusiasm wherever they have been allowed to. The
take-up of glyphosate-tolerant soybean varieties after their
introduction in 1996, for example, rose to well over half
of all the soybeans planted in the United States of America
within 5 years and by 2010, 75% of the global soybean
crop, which covered 100 million hectares, was GM, mak-
ing it difficult to source non-GM soybean. Anecdotally,
farmers cite the following benefits:
• Simpler and more flexible weed control.
• Reduced herbicide costs.
• Easier crop rotation because glyphosate is degraded
rapidly in the soil.
• The ability to switch to a conservation tillage system,
reducing soil erosion and nitrate leaching.
• Peace of mind because weed problems late in the sea-
son can be dealt with if necessary.
The other GM-HT trait on the market at present is
gluphosinate tolerance (Fig. 2). This technology was
developed by Plant Genome Systems, which was subse-
quently bought out by Aventis, which in turn was
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acquired by Bayer. The gene that imparts tolerance to
gluphosinate comes from the bacterium Streptomyces
hygroscopicus and encodes phosphinothrycine acetyl transfer-
ase (PAT), which detoxifies the herbicide (de Block et al.
1987). The technology has been used in oilseed rape,
maize, soybean, sugar beet, fodder beet, cotton, and rice.
Bayer market gluphosinate under the trade name Liberty
and varieties carrying the tolerance trait have the trade
name LibertyLink.
Bayer also acquired the technology for a third GM-HT
trait when they bought Aventis, the herbicides in this case
being oxynil herbicides such as bromoxynil (3,5-dibromo-
4-hydroxybenzonitrile). Bromoxynil and other oxynil her-
bicides inhibit photosynthesis by blocking electron flow
during the light reaction, causing the production of reac-
tive oxygen species (ROS), destruction of cell membranes,
inhibition of chlorophyll formation and death. Tolerance is
imparted by the bxn gene from bacterium Klebsiella ozaenae,
which encodes a nitrilase enzyme that detoxifies the
herbicide (Stalker and McBride 1987). This technology was
used in an Aventis oilseed rape variety, Westar Oxy-235,
which was marketed in Canada in the 1990s. However,
Figure 2. Diagrams illustrating the modes of
action of broad range herbicides: (A) Glyphosate,
(B) Gluphosinate, and (C) Bromoxynil; and the
GM-HT strategies that have been devised to
accompany them. Glyphosate tolerance is
imparted by the introduction of a gene encoding
an enzyme that effectively by-passes the
herbicide, while the strategies for imparting
gluphosinate and bromoxynil tolerance involve
conversion of the herbicide into a nontoxic
derivative.
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Bayer withdrew Westar Oxy-235 in 2002 and there are cur-
rently no bromoxynil-tolerant varieties on the market.
The popularity of GM-HT varieties has raised fears that
they could become victims of their own success, in that
use of the same herbicide over large tracts of agricultural
land for many years will mean that there is intense selec-
tive pressure on weeds to develop resistance, either inde-
pendently or through acquisition of a tolerance gene
through crossing with a GM-HT crop. The latter will, of
course, depend on whether or not sexually compatible
weed species are present where a GM-HT crop is being
grown. There have been reports of the appearance of
weeds that are poorly controlled by glyphosate (Owen
2008), and if left unchecked, the emergence of such weeds
could threaten the use of GM-HT traits. Strategies being
developed to preserve the effectiveness of GM-HT tech-
nology include engineering crops with additional toler-
ance traits, and Monsanto, for example, has announced
that it intends to launch a soybean variety in which
glyphosate tolerance is stacked with a trait imparting tol-
erance to dicamba (3,6-dichloro-2-methoxybenzoic acid),
a pre-emergence herbicide (Behrens et al. 2007). Dicamba
works by promoting plant growth to an unsustainable
level so that the plant dies and is most effective against
dicotyledonous (broadleaved) plants. The tolerance trait
is imparted by a gene from a soil bacterium, Pseudomonas
maltophilia, which encodes an enzyme that converts dica-
mba to 3,6-dichlorosalicylic acid (3,6-DCSA), a chemical
with no herbicidal activity.
Insect resistance
The next most successful GM trait is insect resistance.
Obviously, genetically modifying crop plants to reduce
losses to insect grazing is highly desirable and many strat-
egies have been tried and tested in the laboratory. Of
these, only one has made it into commercial crop varie-
ties, and that is the one based on the Cry genes of a soil
bacterium, Bacillus thuringiensis (Bt). The Cry genes pro-
duce proteins that interfere with insect gut function. Dif-
ferent strains of the bacterium have different Cry genes,
and these are classified into groups, CryI–CryIV, and sub-
groups, A, B, C etc. Each encodes a protein that is effec-
tive against a different type of insect: CryI proteins, for
example, are effective against the larvae of butterflies and
moths, while CryIII proteins are effective against beetles
(reviewed by de Maagd et al. 1999).
As with glyphosate, Bt was already familiar to farmers
before its use in plant biotechnology, in this case because
it had been used as a pesticide for several decades, in the
form of powders, granules, or aqueous, and oil-based
liquids. Such “Bt” pesticides have a narrow host range
and degrade rapidly, so they are not widely used in
mainstream agriculture, but have been adopted by organic
farmers as an “acceptable”, biodegradable pesticide. They
are also popular with salad farmers because they can be
applied immediately before harvest due to their low toxic-
ity to humans, as well as other mammals, birds, and fish.
The long use and excellent safety record of Bt pesti-
cides, plus the fact that the active component was a pro-
tein encoded by a single gene, made the system an
attractive one for crop biotechnology. Genetically modify-
ing a crop plant to produce its own Cry protein over-
comes the problem of rapid loss of activity after
application of the conventional Bt insecticide. The most
successful applications have been with the Cry1A gene,
which has now been introduced into several crop species,
including cotton, sugar beet, rice, soybean, and maize.
GM varieties carrying the trait are usually referred to as
Bt varieties. Their success in a particular area depends on
the effectiveness of the Bt toxin against the pests that are
prevalent. In the case of cotton, for example, Bt controls
three major pests, the tobacco budworm, cotton boll-
worm, and pink bollworm, and in areas where these are
prevalent, such as Alabama, the take-up of Bt varieties in
some years has been as high as 77% and farmers report
applying much less insecticide as a result.
The other Cry gene that has been used in plant
biotechnology is the CryIIIA gene of B. thuringiensis var.
tenebrionsis. The CryIIIA protein is effective against bee-
tles, and potato varieties containing the CryIIIA gene are
resistant to infestation by the Colorado beetle. One such
variety, NewLeaf, produced by Monsanto, was on the
market in the United States of America for several years
in the 1990s, but was withdrawn due to poor sales. The
United States potato plantations are attacked by a number
of pests that are not controlled by Bt, in addition to the
Colorado beetle, and farmers turned to new, broad-range
insecticides instead of the GM option. The NewLeaf
variety also failed to find favor with fast-food chains, a
key market for potatoes in North America.
In the United States of America, the responsibility for
monitoring and controlling the use of most GM crops
lies with the Animal and Plant Health Information
Service (APHIS) within the U.S. Department of Agriculture.
However, Bt crops are the responsibility of the Environ-
mental Protection Agency, which argued that as it was
already responsible for controlling the use of the con-
ventional Bt pesticide, it had to have control of the use
of Bt crops as well. The agency considered the emer-
gence of resistance to Bt to be a significant risk and
insisted that farmers using Bt crops would have to plant
“refuges” of a non-GM variety so that insects that had
developed resistance to the Bt toxin would not be at a
selective advantage. Although not readily accepted by
farmers when it was introduced, this policy appears to
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have worked well. However, Bt crops are now being
grown in developing countries where monitoring and
enforcement are likely to be more difficult than in the
United States of America, and the risk of insects
developing resistance to Bt remains a concern. As with
GM-HT crops, an increase in the diversity of insect
resistance systems would be highly desirable, but there is
no sign of an alternative to Bt being launched in the
near future.
Fruit shelf-life
Extending the shelf-life of fruit would be of obvious bene-
fit to the whole fresh fruit supply chain, from grower to
consumer. Various strategies have been developed to do
this through GM, mainly focused on the production of or
response to the plant hormone, ethylene, which induces
the ripening process. The first GM variety of any kind to
be marketed was the “Flavr Savr” tomato, which was
developed by Calgene, subsequently acquired by Monsan-
to, and marketed in the United States in 1994. “Flavr
Savr” had reduced activity of polygalaturonase (PG), one
of the enzymes that breaks down pectin, as a result of
antisense inhibition (Sheehy et al. 1988). Pectin is a com-
plex group of polysaccharides based on galacturonic acid
and rhamnose, with various sugar side-chains, and its
breakdown is part of the fruit softening process. “Flavr
Savr” was not a success and was soon withdrawn. How-
ever, a competing group led by Don Grierson at the
University of Nottingham and Wolfgang Schuch at Zeneca
(now Syngenta) had developed very similar technology
(Smith et al. 1988). This was eventually commercialized
in the form of tomato paste made from GM tomatoes in
which PG activity was reduced by cosuppression. The
GM tomatoes had a higher content of solids than conven-
tional varieties, reducing waste and processing costs in
paste production and giving a paste of thicker consis-
tency. The product went on the market in many countries
and even proved popular in the United Kingdom where
over two million cans of it were sold between 1996 and
1999.
Reducing PG activity slows down the response to ethyl-
ene. An alternative strategy is to reduce the production of
ethylene, resulting in the fruit developing to the point
where it would normally start to ripen and no further,
allowing the farmer to harvest it all at once. Ripening is
then induced by spraying the fruit with ethylene. Tomato
has again been the main target for the development of
this technology and several methods have been shown to
work. One is to suppress the gene that encodes the
enzyme aminocyclopropane-1-carboxylic acid (ACC) syn-
thase, one of the enzymes in the ethylene synthesis path-
way (Hamilton et al. 1990). A tomato variety of this type
was developed by a company called DNA Plant Technologies
and marketed in the United States of America in the
1990s under the trade name “Endless Summer”. However,
the variety was withdrawn from sale because of disputes
over patenting.
An alternative method with a similar outcome is to
add a gene that encodes an enzyme called ACC deami-
nase. This enzyme interferes with ethylene production by
breaking down ACC. Tomatoes of this type have been
developed by Monsanto using a gene derived from a soil
bacterium called Pseudomonas chlororaphis (Klee et al.
1991), but so far have not been marketed. A third
method targets another of the precursors of ethylene,
S-adenosyl methionine (SAM), by introducing a gene that
encodes an enzyme called SAM hydrolase, which breaks
down SAM (Good et al. 1994); this strategy was devel-
oped by Agritope, Inc., Portland, Oregon using a viral
SAM hydrolase gene, but again has not been marketed.
Clearly, GM tomatoes with delayed ripening traits have
had a chequered history in the west. The technology
works, but tomatoes are a relatively minor crop and pos-
sibly do not generate the revenue required to sustain a
GM program under current constraints of regulation and
public acceptance. The technology could be applied to
other fruit crops, but the same problems would probably
arise. However, slow-ripening GM varieties of tomato and
papaya (Carica papaya) are being grown commercially in
China.
Disease resistance
Herbicide tolerance and insect resistance currently domi-
nate the plant biotechnology market. However, some
other traits have been used successfully in some crops
and in some areas. Virus resistance is an example and this
technology could have important applications in develop-
ing countries in the future, where viruses, such as Cassava
mosaic virus and Feathery mottle virus, among others, are
responsible for the deaths of millions of people every year
through the destruction of vital food crops.
One way of engineering plants to be resistant to viruses
is to exploit the phenomenon of cross protection, in
which infection by a mild strain of a virus induces resis-
tance to subsequent infection by a more virulent strain.
Cross protection involves the coat protein of the virus
and genetically modifying a plant to make a viral coat
protein invokes a similar response. This technology has
been used successfully to engineer papaya to be resistant
to Papaya ringspot virus (PRSV) and a virus-resistant GM
variety has been grown in Hawaii since 1998 (Gonsalves
1998; Ferreira et al. 2002). The cultivation of this variety
remains controversial even now because some important
markets were lost as a result, notably that of Japan, but
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some commentators claim that the GM variety saved the
papaya industry.
Virus resistance can also be achieved by using gene
suppression techniques to block the activity of viral genes
when the virus infects. This technique was used by Monsanto
in the 1990s to engineer resistance to Potato leaf roll virus
(PLRV) into potato by blocking expression of the viral
replicase gene (Lawson et al. 2001). A variety containing
this trait and the Bt insect-resistance trait was marketed
under the trade name NewLeaf Plus but, like the NewLeaf
variety, this was not successful and was withdrawn. How-
ever, virus-resistant papaya, tomato, and sweet pepper
(Capsicum annuum) are being grown commercially for
cultivation in China, and Brazil has just approved for cul-
tivation a GM common bean (Phaseolus vulgaris) (known
as pinto bean in Brazil) that is resistant to Bean golden
mosaic virus (Bonfim et al. 2007). The latter is an example
of research in the public sector, in this case the Brazilian
Agricultural Research Corporation (EMBRAPA), leading
to the development of a crop grown in the main by poor
farmers. Kenya has also field-tested a GM sweet potato
(Ipomoea batatas) variety engineered to be resistant to
Feathery mottle virus and a GM cassava (Manihot
esculenta) variety that is resistant to Cassava mosaic virus,
but so far these varieties have not been approved for
cultivation.
Improved resistance to diseases caused by fungi and
oomycetes is also a target for crop biotechnologists, and
there have been several field trials in Europe of GM
potato lines engineered to be resistant to the oomycete
Phytophthora infestans. One of these lines was produced
by BASF using a gene called RB from a wild potato spe-
cies, Solanum bulbocastanum (Song et al. 2003). Despite
suffering vandalism of field trials in Ireland and Europe,
BASF had obtained sufficient data to apply for consent to
market their blight-resistant potato for cultivation in
Europe. However, in 2012, the company announced that
it was abandoning attempts to develop GM crop varieties
for Europe and would be concentrating on easier markets,
so this technology is likely to be transferred to North
American potato varieties. Two potentially blight-resistant
GM potato lines have also been developed at the John
Innes Centre in Norwich, U.K., one containing the
Rpi-vnt1.1 gene from Solanum venturii, (Foster et al.
2009), the other the Rpi-moc1 gene from Solanum
mochiquense (Smilde et al. 2005).
These GM potato lines have been engineered to express
a gene from a wild potato species, and genetic modifica-
tion is undoubtedly the safest and most efficient method
for moving a gene from a wild potato to a cultivated
potato breeding program. This is because wild potato spe-
cies are diploid, while cultivated varieties are tetraploid,
making the crossing of wild and cultivated potato species
extremely difficult. Furthermore, potatoes contain glycoal-
kaloids such as solanine and chacocine, probably to deter
insects and other herbivores and to defend against fungal
infection. These extremely large organic compounds are
toxic, causing nausea, dizziness, vomiting, diarrhea, heart
arrhythmia, and in extreme cases, coma and death. Their
levels in the tubers of cultivated potatoes have been
reduced by breeders, but the tubers of wild potato species
usually contain much higher levels and consequently are
not considered fit for human consumption.
An alternative approach to the challenge of engineering
fungal resistance into crop plants is to modify them with
genes that express fungicidal proteins. Examples are genes
encoding the enzymes chitinase and ß-glucanase, both of
which attack the cell walls of fungal hyphae as they enter
the plant. Transgenic plants containing genes for these
enzymes have been reported to have increased resistance
to pathogenic fungi under experimental conditions, (Punja
and Raharjo 1996; Anand et al. 2003), although success of
the strategy appears to vary from species to species.
Modified oil content
Plant oils contain a variety of fatty acids with different
chain lengths and degrees of saturation (Table 1). Well-
known plant fatty acids include lauric acid (12 carbon
atoms, no double bonds; 12:0) and palmitic acid (16:0),
which are found in coconut and palm kernel oil, and
stearic acid (18:0), a major component of cocoa butter.
Common unsaturated fatty acids include oleic acid (18:1),
which contains a double bond at position 9 with respect
to the methyl (omega) end of the molecule (n-9), and is
the major constituent of olive and oilseed rape oil. Lino-
leic acid (LA) (18:2, n-6) (Fig. 3) is found in safflower
(Carthamus tinctorius), sunflower, and maize oil, and
makes up about 20% of oilseed rape oil. Gamma linolenic
acid (GLA) (18:3, n-6) (Fig. 3) is another omega-6 fatty
acid and is identical to LA except that it has an additional
double bond at n-12; starflower (borage) (Borago officinalis)
oil contains more GLA than any other, but evening prim-
rose (Oenothera biennis) oil is also a good source. Alpha
linolenic acid (ALA) (18:3, n-3) is similar to GLA, but
crucially, the double bonds are situated at different posi-
tions, with the first at n-3 with respect to the methyl end,
making ALA an omega-3 fatty acid.
LA is an essential fatty acid because humans do not syn-
thesize it, and GLA is often described as essential because
it can only be synthesized from LA; GLA may be particu-
larly important for people with diabetes, who appear to
convert LA to GLA inefficiently. LA and GLA are precur-
sors for longer chain omega-6 fatty acids such as aracha-
donic acid (AA; 20:4, n-6) (Fig. 3) that are not present in
plant oils. AA is present in the phospholipids of cell
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membranes and is abundant in the brain and muscles; it is
also used to make eicosanoids, such as prostaglandins, leu-
kotrienes, and isoprostanes, which have a variety of roles
in the body. Dietary intake is from meat, eggs, and dairy
products, so it is not present in the diet of vegans, for
whom consumption of adequate amounts of LA or GLA
from plant sources is particularly important.
Plant oils have long been used for industrial as well as
food uses, and this has risen greatly in the last decade or
so with the increased use of oils to make biodiesel, usu-
ally after esterificatrion with methanol to create fatty acid
methyl esters (FAMEs). Erucic acid (22:0) is an example
of a plant oil with many industrial applications, from
transmission oils to health care products. It is toxic, and
its presence in oilseed rape oil is one of the reasons why
oilseed rape oil used to be regarded as unfit for human
consumption. Plant breeding, including an intense pro-
gram of mutagenesis, reduced the levels of erucic acid to
the point where oilseed rape oil was considered edible,
giving rise to an alternative name for the crop, canola
(Canadian oil, low erucic acid), which was adopted
throughout the Americas. Edible varieties typically con-
tain oleic acid (60%), LA (20%), and ALA (10%), with
palmitic, stearic, and other fatty acids together accounting
for the other 10%.
Genetic modification has been used to change oilseed
rape oil further: Calgene developed a GM oilseed rape
variety containing a gene from the Californian Bay plant
(Umbellularia californica) that encodes an enzyme that
causes premature chain termination of growing fatty acid
chains, resulting in the accumulation of high levels (40%)
of lauric acid (12:0) (Voelker et al. 1992). This variety
was introduced in 1995 to compete in the detergents and
shampoo market, but failed to gain ground against palm
and coconut oil. The technology is now owned by
Monsanto, but there is no cultivation of high lauric acid
oilseed rape at present.
More success has been had in the genetic modification
of soybean to alter its oil content. A GM variety, Plenish,
in which the activity of a gene encoding a delta-12 desat-
urase enzyme that converts oleic acid to LA is reduced,
has been produced by PBI, a subsidiary of DuPont. This
variety accumulates oleic acid to approximately 80% of
its total oil content, compared with 20% in non-GM vari-
eties (Kinney 1997). Monsanto also has a high oleic acid
variety, Vistive, on the market; this is a GM variety
because it carries the glyphosate tolerance trait, but the
high oleic acid trait was developed by mutagenesis, not
GM. The high oleic acid oil from these varieties is
claimed to be much more stable during frying and cook-
ing, less prone to oxidation and therefore less likely
to form compounds that affect flavor (Mounts et al.
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oxidation, but this can create trans fatty acids, which con-
tain double bonds in a different orientation to the cis
fatty acids present in natural plant oils. Trans fatty acids
raise blood cholesterol, potentially contributing to cardio-
vascular disease, and U.S. law now requires that trans
fatty acid content be included in the information in food
labels. The better heat stability of high oleic acid soybean
oil also makes it suitable for industrial uses (Cahoon 2003).
Farmers only gain from growing varieties like these if
they get a premium price for them. The introduction of
labeling legislation for trans fatty acids in 2005 led to a
significant increase in adoption of high oleic varieties, but
it has undoubtedly been more difficult to sell “output” as
opposed to “input” traits to farmers and the area of culti-
vation of high oleic varieties remains relatively small. One
potential problem with these varieties is that, while reduc-
ing trans fatty acid content of foods is a worthy target,
LA and ALA are important dietary fatty acids, and it is
unlikely that consumers will be aware and understand the
significance of the differences between conventional soy-
bean oil and oil from these GM varieties.
Genetic modification is also being used to enhance the
levels of long chain polyunsaturated fatty acids (LC-PU-
FAs) in crop plant oils or to produce valuable LC-PUFAs
that are not normally present in plant oils. GLA was an
early target in this work because the plant species for
which it is a major oil constituent, namely evening prim-
rose and starflower (borage), make poor crops. In a proof
of concept experiment, tobacco has been engineered to
produce GLA using a gene from starflower encoding a
delta-5 desaturase (Sayanova et al. 1997), and engineering
of Arabidopsis with multiple transgenes has shown that it
is possible to produce arachidonic acid itself in plants (Qi
et al. 2004). However, the technology has not yet been
commercialized.
Omega-3 LC-PUFAs such as eicosapentaenoic acid
(EPA) (20:5) and docosahexaenoic acid (DHA) (22:6)
(Fig. 3) are also targets for biotechnologists. The only
Figure 3. Diagram illustrating the structures of
some well-known fatty acids. Oleic acid is an
18-carbon mono-unsaturated fatty acid found
in olive and other naturally occurring oils and in
GM soybean varieties with modified oil content.
Linoleic acid and gamma linolenic acid are
18-carbon omega-6 poly-unsaturated fatty
acids present in some plant oils, while
arachidonic acid is a 20-carbon omega-6 fatty
acid that is not present in any plant oils. The
18-carbon omega-3 fatty acid, alpha linolenic
acid, is also shown, along with the longer chain
omega-3 fatty acids, eicosapentaenoic acid and
docosahexaenoic acid, that are synthesized by
marine algae and found in fish oils. The
numbers in red indicate the first and last
carbon in the chain, taking the carbon at the
methyl end of the chain as 1, and the positions
of double (unsaturated) bonds between the
carbon atoms.
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dietary source for omega-3 LC-PUFAs at the moment is
marine fish oil. The human body can synthesize them
from ALA, but the efficiency is low: approximately 5% in
men and slightly higher in women. Eicosanoids derived
from omega-3 LC-PUFAs act to modulate platelet aggrega-
tion and immuno-reactivity. There is also increasing evi-
dence of the effectiveness of omega-3 LC-PUFAs in the
prevention of cardiovascular disease, metabolic syndrome
and type 2 diabetes. Furthermore, fetal development is
now known to require omega-3 LC-PUFAs and both EPA
and DHA are commonly added to infant formula milk.
EPA and DHA are in fact made by marine algae, not
fish; they are present in fish oils only because they accu-
mulate through the marine food chain. Marine fish
stocks are in decline and farmed fish, like marine fish,
acquire EPA and DHA in their diet, through being fed
marine fish meal, so farmed fish currently cannot be
considered to be a sustainable source of these fatty acids
either. Finding a sustainable alternative source is there-
fore essential and the development of GM plants produc-
ing EPA and DHA is an obvious solution. Proof of
concept has been demonstrated in Arabidopsis using
multiple transgenes (Qi et al. 2004) and several biotech
companies claim to be close to launching commercial
varieties of soybean and oilseed rape that produce EPA
and DHA.
Modified Starch, Biofuels, and High
Lysine Animal Feed
Nonfood uses of starch include the manufacturing of
paper, adhesives, gypsum wall boards, and textile yarns,
among many others. Starch is, of course, a glucan, made
up of chains of glucose units, but it comprises two com-
ponents, amylose, consisting of long, unbranched chains
of glucose units, and amylopectin, consisting of branched
chains. A difficulty in using starch for industrial purposes
is that amylose and amylopectin have different character-
istics and have to be separated or modified chemically
before use. Amylose, for example, has gelling properties
that are undesirable in some processes. The production of
GM potatoes in which the starch was composed almost
entirely of amylopectin as a result of reduced activity of a
granule-bound starch synthase was reported in 1991 (Vis-
ser et al. 1991) and BASF used this technology to produce
a commercial GM potato variety, marketed as “Amflora”.
Amflora was developed for the European market and
was mired in the EU’s regulatory processes covering the
use of GM crops for over a decade. It was finally
approved for cultivation in 2010 and BASF cultivated
Amflora in Germany and Sweden in 2011 to produce seed
potatoes. However, BASF announced in 2012 that it was
withdrawing from plant biotechnology in Europe
altogether and concentrating on markets elsewhere. Cur-
rently, it has no plans to continue with Amflora.
Starch can be used to produce sugars through enzy-
matic digestion, and maize starch, for example, has been
an important source of sugars in the food industry in the
United States of America for many years. More recently,
there has been a huge increase in the use of sugars
derived from starch for the production of ethanol for
transport fuel. In the United States of America, for exam-
ple, bioethanol production from maize starch saw an
annual growth rate of 25% between 2003 and 2007 and
in 2010 bioethanol production took a third of the U.S.
maize crop. Several plants designed to produce biofuel
from wheat grain have been or are being built in the
United Kingdom, the largest expecting to take over a million
tonnes of grain per year and produce up to 400 million
liters of ethanol and 350 thousand tonnes of animal feed
coproduct. One fifth of the U.K.’s wheat harvest could be
used for fuel production by 2015. However, development
of these plants is currently stalled in the face of cheap
imported ethanol and it is not clear how the industry is
going to develop.
Bioethanol production from cereal grains generally uses
a “dry-grind” process in which the entire kernel is ground
into a coarse flour, then slurried with water. The resulting
mash is then cooked, treated with enzymes, fermented,
and distilled. The first enzyme to be added is a-amylase to
produce maltotriose, maltose, and limit dextrin (a mixture
of branched and unbranched glucans) in a process known
as gelatinization and liquefaction. Gluco-amylases are then
added to achieve saccharification, in which smaller sugars
are produced, ready for fermentation. The yield of sugar
from starch is the most important cost determinant in
bioethanol production and is a target for biotechnologists.
Syngenta have already produced a GM maize variety that
it claims gives a better yield of ethanol in the dry-grind
process (Johnson et al. 2006). It contains a gene, amy797E,
from a thermophilic bacterium, Thermococcales spp., that
encodes a highly thermostable a-amylase. It was deregulated
by the U.S. authorities in early 2011.
Another target for improvement of starchy crops used
for bioethanol is the quality of the high-protein coprod-
uct used in animal feed. Cereal grain usually has to be
supplemented in animal feed because it contains insuffi-
cient amounts of the essential amino acid lysine. Renes-
sen, a joint venture between Cargill and Monsanto, has
produced a maize variety with high lysine levels through
expression of a gene from a bacterium Corynebacterium
glutamicum encoding a lysine-insensitive dihydrodipicoli-
nate synthase (DHDPS) (Huang et al. 2005). Feedback
inhibition of DHDPS is the major regulatory control for
flux through the lysine biosynthesis pathway in plants,
but the bacterial enzyme is not affected by lysine, allowing
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the amino acid to accumulate to high levels. Mavera is
currently being grown entirely for U.S. domestic bioetha-
nol/animal feed production. It also contains a triple stack
of input traits (resistance to corn rootworm and the
European corn borer and tolerance of glyphosate) and is
an indication of where maize biotechnology in the United
States is heading. As such, it should sound alarm bells for
European maize growers and regulators.
Golden Rice
Vitamin A deficiency is common in children in develop-
ing countries who rely on rice as a staple food. It
causes symptoms ranging from night blindness to those
of xerophthalmia and keratomalacia, where the cornea
and conjunctiva become extremely dry, wrinkled, thick
and ulcerated, sometimes leading to total blindness.
Over five million children develop these conditions
annually and approximately 250,000 of them become
blind. Vitamin A deficiency also exacerbates major kill-
ers of children, such as diarrhea, respiratory diseases,
and measles, and improving Vitamin A status in chil-
dren reduces death rates by 30–50%. However, the
World Health Organisation’s efforts to eradicate vitamin
A deficiency have been hampered by the difficulty of
reaching those in need.
One potential solution would be to distribute rice vari-
eties that contain vitamin A or its precursor, b-carotene.
There is no way of producing such a variety by conven-
tional breeding, but a GM line containing b-carotene was
developed over a decade ago by Ingo Potrykus, a biotech-
nologist at the Swiss Federal Institute of Technology in
Zurich (Ye et al. 2000; Beyer et al. 2002; Potrykus 2003).
Rice endosperm contains geranylgeranyl diphosphate,
which is converted into b-carotene by three enzymes
produced from different transgenes: phytoene synthase
(psy) and lycopene b-cyclase genes from daffodil (Narcis-
sus pseudonarcissus), and a phytoene desaturase (crtI) gene
from the bacterium Erwinia uredovora (Fig. 4). The GM
rice producing b-carotene was crossed with another line
engineered with multiple genes to improve iron availabil-
ity, including a phytase-encoding gene from Aspergillus
fumigatus (Lucca et al. 2001). The high b-carotene/high
available iron hybrid was called Golden Rice.
In a press release of February 2001, the pressure group
Greenpeace described Golden Rice as “fool’s gold”, claim-
ing that an adult would have to eat at least 3.7 kg of dry
rice (12 times the normal intake of 300 g) to get the daily
recommended amount of b-carotene. Potrykus responded
that nutritional experts involved in the project believed
that the levels of b-carotene present in Golden Rice
would have a significant effect in preventing blindness
and other symptoms associated with severe vitamin A
deficiency. Greenpeace dropped the issue when the devel-
opment of Golden Rice 2 was announced; this line had
been produced by Syngenta in collaboration with
Potrykus by replacing the daffodil phytoene synthase gene
with one from maize and it contained many times more
pro-vitamin A than Golden Rice 1.
The production of high b-carotene rice was first
reported in 2000 (Ye et al. 2000), 12 years ago, and by
2001, Golden Rice was already being crossed into local
varieties by centers such as The Rice Research Institute in
Manila, The Philippines. However, the release of Golden
Rice-derived varieties to farmers has been held up by gov-
ernments concerned about their export markets in Europe
and Japan, where resistance to GM crops has been strong-
est. In this case, therefore, European attitudes and over-
regulation are costing thousands of lives in developing
countries.
Figure 4. Diagram showing the biosynthetic
pathway for b-carotene that was engineered
into Golden Rice, from geranyl geranyl
pyrophosphate, a precursor that is naturally
present in rice endosperm (Ye et al. 2000). In
Golden Rice 2, the phytoene synthase gene
from daffodil is replaced with one from maize.
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Drought Tolerance
Plants may avoid late summer drought (typical of the
U.K. and northern Europe) by growing, flowering, and
setting seed before this time. They can also avoid becoming
water-stressed by developing deeper and more extensive
root systems. Plants have also evolved tolerance traits that
enable them to survive even if they do become short of
water. These response strategies differ from species to spe-
cies and even between different varieties, developmental
stages, organs, and tissue types, but most involve abscisic
acid (ABA), which initiates a network of signaling path-
ways in response to water stress.
ABA signaling involves SNF1-related protein kinase-2
(SnRK2) and protein phosphatases of the PP2C family
(Cutler et al. 2010) (Fig. 5); in the absence of ABA, PP2C
inactivates SnRK2 by dephosphorylation of one of the
serine residues in the activation loop (Umezawa et al.
2009). If ABA is present, the PYR/PYL/RCAR ABA recep-
tors (Nishimura et al. 2010) bind to and inhibit PP2Cs,
allowing the accumulation of active SnRK2s and subse-
quent phosphorylation of ABA-responsive element bind-
ing proteins (AREBPs) (Cutler et al. 2010). AREBPs (also
known as ABFs) are a family of basic leucine zipper
(bZIP) transcription factors that recognize the G-box
binding sites known as ABA response elements (ABREs)
present in some ABA-regulated genes (Cutler et al. 2010).
Recent evidence suggests that ABA may also cause degra-
dation of SnRK1, a protein kinase related to SnRK2 that
is a master regulator of carbon metabolism (Coello et al.
2012), and calcium-dependent protein kinases have also
been implicated in drought responses (Saijo et al. 2000).
Other transcription factors known to be involved in
drought stress responses include dehydration-responsive
element binding protein (DREB)-1 and -2, members of
the zinc-finger homeodomain (ZFHD)-1, myeloblastosis
(MYB), and myelocytomatosis (MYC) families, and the
NAC family, which comprises no apical meristem
(NAM), ATAF1 and 2, and cup-shaped cotyledon (CUC)
transcription factors (reviewed by Semenov and Halford
2009). The action of AREBPs, DREB1, MYC, and MYB
requires ABA, while that of DREB2, ZFHD1, and NAC
does not. Over-expression of another transcription factor,
plant nuclear factor-Y (NF-Y), has been shown to confer
increased drought tolerance in maize in the field (Nelson
et al. 2007). One of the areas of plant metabolism that is
affected by these signaling pathways is carbohydrate
metabolism, which plants manipulate to mitigate the
effects of osmotic stress brought about by drought, for
example, by interconverting insoluble starch or fructan
with soluble sugars (reviewed by Halford et al. 2011).
Clearly, the genes involved in drought stress responses
are potential candidates for manipulation to improve
drought tolerance in crop plants. However, Monsanto,
not for the first time, has taken the approach of using a
bacterial gene in crop biotechnology and has developed
drought-tolerant maize varieties Genuity VT Triple Pro
and Genuity VT Double Pro, in collaboration with BASF,
that express a Bacillus subtilis RNA chaperone, cspB
(Castiglioni et al. 2008). These varieties look set to be
made available to farmers in 2012.
Biopharming
Biopharming is the term applied to the use of GM plants
to produce pharmaceuticals, vaccines, antibodies, and
enzymes. It is one of the most exciting areas of plant bio-
technology and there are already examples of projects that
have been commercialized or are in the later stages of
development. In 2007, for example, a Canadian company,
Sembiosys, announced that it had modified safflower to
produce insulin in its seeds. The possibility of producing
vaccines and antibodies in GM plants has also been caus-
ing some excitement (Nicholson et al. 2006). Progress has
been slow, but the company, ProdiGene, based in Texas,
has produced an edible vaccine for transmissible gastroen-
teritis virus (TGEV) in pigs (Lamphear et al. 2004), while
a monoclonal antibody, Guys 13, has been produced in
tobacco (Ma et al. 1994). This antibody binds to the sur-
face protein of Streptococcus mutans, the bacterium that
causes tooth decay. The technology is now licensed to
Planet Biotechnology Inc., Hayward, California and is
undergoing clinical trials under the product name
CaroRxTM.
An example of the production of an enzyme for indus-
trial uses is trypsin, an animal protease that has a variety
of applications in research and the food industry. Prodi-
Gene has engineered maize to produce bovine trypsin and
is marketing the enzyme under the trade name TrypZean
(Woodward et al. 2003).
Maize is, of course, an outbreeder, and it will also pro-
duce volunteers in subsequent crops if not prevented
from doing so; its use in the production of pharmaceuti-
cals and other products that should not enter the food
chain is therefore something of a risk. In 2001, ProdiGene
contracted a Nebraska farmer to grow an experimental
GM maize variety and the next year, the farmer was
allowed to plant soybeans destined for human consump-
tion on the same land. A tiny amount (65 g) of GM
maize material was discovered in the harvested soybean
seed and the Food and Drug Administration ordered the
soybean crop, worth $2.7 million, to be destroyed. No
doubt ProdiGene and the U.S. regulatory authorities
learned from this mistake, but the episode does highlight
the issue of segregating crops producing pharmaceuticals
from food crops.
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Current Status and Prospects
A striking aspect of the list of traits in the previous sec-
tion is that it remains relatively short. As we approach
the end of the second decade of GM crops, the number
of traits being used successfully in commercial agriculture
remains in single figures. There are others that may be on
the way, such as salt and heat tolerance, and hypoallerge-
nicity, but compared with the many thousands of GM
lines that have been produced in plant genetic research,
the number that have been developed into commercial
varieties is tiny.
Nevertheless, some of the GM crops that have made
it onto the market have been staggeringly successful.
Data on the global use of GM crops have been com-
piled for several years by Clive James of the Interna-
tional Service for the Acquisition of Agri-Biotech
Applications (ISAAA; www.isaaa.org). It is almost
impossible to check the ISAAA’s data for some coun-
tries, but for countries where independent data are
available from other sources, the U.S.A., for example,
the data sets are consistent. According to the ISAAA,
the worldwide area of land planted with GM crops in
2011 was 160 million hectares (James 2011). Most
(75%) of the global soybean production was GM, while
82% of cotton, 32% of maize, and 26% of oilseed rape
production was GM. Other crops with some GM varieties
being grown commercially included papaya, squash,
tomato, alfalfa, tobacco, sweet pepper, poplar, potato,
and sugar beet. GM crops were grown in 29 countries
(Table 2), with the U.S.A., Brazil, Argentina, India, and
Canada each planting more than 10 million hectares of
GM crops, and China, Paraguay, Pakistan, South Africa,
and Uruguay all planting more than a million hectares.
Herbicide tolerance and insect resistance were the domi-
nant traits, with approximately 95 million hectares of
GM-HT crops, 43 million hectares of Bt crops, and 25
million hectares of crops in which the two traits were
stacked. Second-generation (quality) traits are beginning
to emerge, but these are being marketed and will almost
certainly continue to be marketed on the back of suc-
cessful, first-generation (input) traits.
Figure 5. Diagram illustrating the abscisic acid
(ABA) signaling pathway (Cutler et al. 2010),
which is a target for biotechnologists in the
improvement of crop stress tolerance. Top:
Under normal conditions, the protein kinase
SnRK2 is kept in an inactive state by the action
of protein phosphatase PP2C. It is therefore
unable to carry out its function of
phosphorylating and activating ABA response
element binding proteins (AREBPs). Bottom:
When ABA is present, it is sensed by the PYR/
PYL/RCAR receptor, which binds to and inhibits
PP2C. Phosphorylated, active SnRK2 then
accumulates and activates AREBPs, resulting in
the expression of multiple ABA-responsive
genes.
© 2012 The Author. Food and Energy Security published by John Wiley & Sons Ltd. and the Association of Applied Biologists. 23
N. G. Halford Plant Biotechnology
There are some notable absentees from the list of crop
species for which a biotech market has been established.
There is currently no GM wheat being grown commercially
on a significant scale, for example, and while China has
approved some GM rice varieties for cultivation, they have
not yet been released to farmers. The only GM potatoes
being grown in 2011 were of the Amflora variety, which
has now been withdrawn. There are also some notable
absentees from the list of countries where GM crops are
being grown, including Japan and most countries in Africa
(where arguably crop improvement is most needed) and
Europe. The only significant cultivation of GM crops in
Europe is that of GM maize in Spain, and even that
amounts to less than 100,000 hectares. Glyphosate-tolerant
soybean was grown in Romania up to 2006, when there
were approximately 120,000 hectares of it, but this disap-
peared entirely in 2007 because Romania joined the EU.
There have been many studies on the economic impact
of GM crops and I will not review them here. A report
submitted to the EU by Kaphengst et al. (2011) of the
University of Reading, the Swiss Federal Institute of Tech-
nology, Zurich and the Ecologic Institute of Berlin, which
reviewed much of the available data, found that “Positive
economic effects of GM crops have been indicated in this
study for several countries, which is in line with other review
studies and explains the high adoption rates of GM crops in
these countries. But the study also underlines……that such
outcomes cannot be generalized across the globe.” Economic
benefits are not the only reasons why farmers might
choose to adopt GM crops, of course. Peace of mind cer-
tainly seems to have been a factor in the adoption of
glyphosate-tolerant crops, for example; anecdotally, farm-
ers appear to have enjoyed the security of knowing that
they can deal with late season weed problems if necessary.
The situation in Europe remains extremely difficult,
and the wet blanket of European attitudes and over-regu-
lation extends well beyond Europe’s boundaries because
of the value of the huge European market. Only three
African countries, for example, South Africa, Burkina
Faso, and Egypt, have approved the use of GM crops,
partly because of fears over losing access to the lucrative
European market. The development of crop biotechnol-
ogy in Europe itself has been stymied by several con-
nected factors, first of which is the issue of regulation.
Under the EU’s directive, GM Food and Feed Regulation
(EC) No. 1829/2003, the regulation of GM crop use and
release is under the control of the European Commission.
The EU recognizes two different types of field release of
GM crops, one for research purposes only (a Part B
release) and the other for commercial release (a Part C
release). Consent for a Part C release may be granted for
cultivation, food and feed use, or for food and feed use
alone. While permission for a Part B release can be
granted by an individual Member State, applications for a
Part C release anywhere in the EU have to be approved
by the European Commission.
Applications for Part C consent are assessed by EFSA. If
EFSA approves the application, it is voted on by a working
group with representatives from all 25 Member States,
who may take advice from their own national experts. The
U.K. representative, for example, may consult one or more
of three advisory committees, the Advisory Committee for
Releases to the Environment (ACRE), the Advisory Com-
mittee on Novel Foods and Processes (ACNFP), and the
Advisory Committee on Animal Feedingstuffs (ACAF).
Table 2. Global GM crop cultivation 2011 (James 2011 and pers.
comm.).
Country GM crop area Crops
U.S.A. 69,000,000 Maize, soybean, cotton,
oilseed rape, sugar beet,
alfalfa, papaya, squash
Brazil 30,300,000 Soybean, maize, cotton
Argentina 23,700,000 Soybean, maize, cotton
India 10,600,000 Cotton
Canada 10,400,000 Oilseed rape, maize,
soybean, sugar beet






South Africa 2,300,000 Maize, soybean, cotton
Uruguay 1,300,000 Soybean, maize
Bolivia 900,000 Soybean
Philippines 600,000 Maize
Australia 700,000 Cotton, oilseed rape
Myanmar (Burma) 300,000 Cotton
Burkina Faso 300,000 Cotton
Mexico 200,000 Cotton, soybean
Spain 100,000 Maize
Chile <50,000 Maize, soybean, oilseed rape
Colombia <50,000 Cotton
Costa Rica <50,000 Cotton, soybean









Total 160,000,000 Alfalfa, cotton, maize,
oilseed rape, papaya,
poplar, soybean, squash,
sugar beet, sweet pepper,
tomato
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Applications are voted on through a complicated system
of Qualified Majority Voting (QMV), meaning that it is
relatively easy for a minority of countries to block an
application, and the European Commission failed to
approve a single application between 1998 and 2004
because six member states, France, Italy, Denmark, Greece,
Austria, and Luxembourg, blocked every one.
Even when the impasse was broken in May 2004 with
the approval of an insect-resistant and gluphosinate-toler-
ant sweetcorn from Syngenta, it was only for food and
feed use, not for cultivation, and Austria, France,
Germany, Luxembourg, and Greece retained their own
national bans in defiance of the European Commission.
In 2006, the World Trade Organisation (WTO) ruled that
the EU’s position was illegal and also criticized the bans
imposed by individual Member States. Nevertheless,
Austria and Hungary still ban GM crops and their prod-
ucts outright, and there are still only two GM varieties
approved for cultivation in Europe, the Amflora potato
(now withdrawn) and Mon 810, the Bt maize variety
grown in Spain and to a lesser extent in Romania, Slova-
kia, the Czech Republic, and Portugal. Efforts to develop
new varieties for cultivation in Europe have all but been
abandoned by biotech companies. Instead, companies are
focusing on obtaining permission for GM crop products
to be imported for food and feed use so that farmers else-
where in the world can be reassured that the European
market is open to their products.
Even small-scale field trials of GM lines are extremely
difficult to run in Europe, and in the United Kingdom,
for example, there have only been three in the last decade,
an astonishing fact when set against the tens of thousands
of field trials that have been carried out in the United
States alone during the same period. The approval process
is long and expensive, and field trials attract national and
local headlines and a hostile reaction from activists.
Figure 6 shows the drilling of a field trial at Rothamsted
Research in the United Kingdom to assess aphid, preda-
tor, and parasitoid behavior in wheat producing an aphid
alarm pheromone (Beale et al. 2006). The trial is pro-
tected by fencing and a 24-h security presence to prevent
vandalism, which may seem bizarre, given that 160 mil-
lion hectares of GM crops are being grown elsewhere in
the world, but is necessary if the trial is to survive.
There is no scientific justification for the continuation
of Europe’s restrictive regulatory framework. There is a
broad scientific consensus that GM is not inherently more
risky than other methods in plant breeding; indeed, it is
arguably more predictable than techniques such as ran-
dom mutagenesis. A comparison of the metabolite profiles
of three GM wheat lines and their non-GM parents grown
at different sites in the United Kingdom over 3 years, for
example, found that the differences in grain composition
caused by site and year of cultivation were greater than
those caused by the genetic modification (Baker et al.
2006). Another study compared global gene expression
patterns in transgenic and conventionally bred wheat lines
and found that the differences between conventionally
bred genotypes were much larger than those between GM
and non-GM genotypes (Shewry et al. 2007).
Even if a GM crop or crop product makes it onto the
market in Europe, it must comply with labeling controls
covering GM foods and feed. These were introduced in
Europe in 1997 and extended in 2004 through directives
on the regulation of GM food and feed (1829/2003) and
the traceability and labeling of GMOs (1830/2003). These
regulations require that any food containing material
from GM crops must be labeled, unless the GM material
is present through accidental mixing and does not exceed
0.9% of the total. This zero tolerance rule for products
that have been approved elsewhere but are not yet
approved in Europe (the issue of asynchronous approvals)
is becoming increasingly unworkable as the amount of
GM material in imported food and feed increases. The
regulations cover animal feed, but not meat, dairy or
other products from GM-fed animals or enzymes pro-
duced in GM micro-organisms and used widely in the
production of cheeses, yogurts, and other foods.
Biotech companies also have to consider whether or
not their product will find a market. In the United
Kingdom, consumer hostility to GM crop products has
declined; indeed, the proportion of respondents to a Food
Standards Agency survey who, unprompted, listed GM
food as a concern fell from 18% in 2004 to only 4% in
2011 (Food Standards Agency 2012). Nevertheless, the
retail and food sectors in the United Kingdom and the
Figure 6. Field trial of GM wheat at Rothamsted Research in the
United Kingdom in 2012. The small trial is one of a handful that has
been attempted in the United Kingdom in the last decade and is
surrounded by security fencing to prevent vandalism. Picture kindly
provided by Rothamsted Research.
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rest of Europe remain extremely reluctant to use GM
products, fearful of consumer fears being whipped up
again by pressure groups who remain implacably opposed
to GM. The animal feed market, on the other hand, has
been using GM products on a large scale for the best part
of a decade, because it has become difficult and expensive
to source non-GM soybean, maize, and other essential
raw materials.
This situation has arisen because science lost the GM
debate. The consequences have been severe: Currently no
GM crops are being developed specifically for European
conditions or the European market; the biotech industry
is focused on obtaining consent for import of more GM
crop products into Europe, not for GM crop cultivation;
European farmers are increasingly disadvantaged in a
competitive global market, competing with GM crops, but
unable to use them; biotech multinationals have largely
moved out of Europe and the home-grown industry has
been lost; the U.S., China, India, Brazil and others have a
huge lead over Europe in a key 21st-century technology.
At some point, the debate will have to be reopened and
the hearts and minds of the European public won over.
The context and urgency of the debate are very different
from what they were in the late 1990s: World population
passed seven billion in 2011; increased prosperity and the
ability to pay for a better diet in China, India and else-
where are pushing up global food demand; severe weather
events such as the droughts in Australia in 2006–2007
and Russia in 2010 may be the portent of things to come
as the climate changes; biofuel is competing with food for
crop products; peak oil (the point when the maximum
rate of global petroleum extraction is reached, after which
the rate of production enters terminal decline) is
approaching and current crop yields are heavily fossil
fuel-dependent; and there are concerns about fresh water
supply, soil erosion, salination, pollution, and the loss of
agricultural land to other uses. All this has led to an
upward trend in food prices. In December 2010, the
London International Financial Futures and Options
Exchange (LIFFE) wheat price hit a record of £200 per
tonne. It has fallen back since, but is currently still at a
historically high price of £178 for May 2012. The era of
cheap food and global food surpluses has already ended,
and if we are to have food security in the coming dec-
ades, plant breeding will have to play its part and plant
breeders will have to be able to use every tool that is
available, including biotechnology.
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